Skip to main
CL

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive (CL) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 41%
Buy 35%
Hold 24%
Sell 0%
Strong Sell 0%

Bulls say

Colgate-Palmolive is a leading player in the household and personal care industry, with a diverse product portfolio that includes oral care, personal care, and home care products sold in over 200 countries. The company's strong presence in emerging markets and its focus on premiumization and innovation position it well for long-term growth. Additionally, its Hill's segment, which offers specialty pet food, has consistently shown strong performance. While there may be some near-term volatility in input costs, Colgate-Palmolive's strong execution and cost-saving initiatives make it an attractive investment opportunity.

Bears say

Colgate-Palmolive is facing major challenges which are affecting its financial performance and growth prospects. These include increased raw material and logistics costs, underperformance in key markets such as North America, and competition from other major players in the industry. Additionally, external factors such as volatility in emerging market currencies and recessionary pressures pose significant risks to the company's profitability. Despite mergers and acquisitions, the company has failed to diversify its product portfolio and reduce dependence on its flagship oral care line. These challenges will continue to weigh on the company's financials and hinder its long-term growth potential.

Colgate-Palmolive (CL) has been analyzed by 17 analysts, with a consensus rating of Buy. 41% of analysts recommend a Strong Buy, 35% recommend Buy, 24% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Colgate-Palmolive and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Colgate-Palmolive (CL) Forecast

Analysts have given Colgate-Palmolive (CL) a Buy based on their latest research and market trends.

According to 17 analysts, Colgate-Palmolive (CL) has a Buy consensus rating as of Jul 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $96.88, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $96.88, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Colgate-Palmolive (CL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.